JP3145237B2 - Silicone hydantoin derivatives, UV absorbers and skin external preparations - Google Patents

Silicone hydantoin derivatives, UV absorbers and skin external preparations

Info

Publication number
JP3145237B2
JP3145237B2 JP26583893A JP26583893A JP3145237B2 JP 3145237 B2 JP3145237 B2 JP 3145237B2 JP 26583893 A JP26583893 A JP 26583893A JP 26583893 A JP26583893 A JP 26583893A JP 3145237 B2 JP3145237 B2 JP 3145237B2
Authority
JP
Japan
Prior art keywords
silicone
present
skin
hydantoin derivative
hydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP26583893A
Other languages
Japanese (ja)
Other versions
JPH0797383A (en
Inventor
裕幸 西尾
Original Assignee
カネボウ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カネボウ株式会社 filed Critical カネボウ株式会社
Priority to JP26583893A priority Critical patent/JP3145237B2/en
Publication of JPH0797383A publication Critical patent/JPH0797383A/en
Application granted granted Critical
Publication of JP3145237B2 publication Critical patent/JP3145237B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、新規なシリコーン系ヒ
ダントイン誘導体、紫外線吸収剤及び皮膚外用剤に関す
る。さらに詳しくは、シリコーン油に溶解し、耐水及び
耐油性に優れ、かつUV−A領域の波長の紫外線吸収特
性を有する新規なシリコーン系ヒダントイン誘導体に関
するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel silicone hydantoin derivative, an ultraviolet absorbent and an external preparation for skin. More specifically, the present invention relates to a novel silicone hydantoin derivative which is soluble in silicone oil, has excellent water resistance and oil resistance, and has an ultraviolet absorbing property at a wavelength in the UV-A region.

【0002】[0002]

【従来の技術】紫外線は、様々な変化を皮膚にもたらす
ことが知られている。紫外線を皮膚科学的に分類すると
400〜320nmのUV−Aと呼ばれる長波長紫外線、
320〜290nmのUV−Bと呼ばれる中波長紫外線、
290nm以下のUV−Cと呼ばれる短波長紫外線とに分
けられる。通常、人間が曝露される紫外線の大部分は太
陽光線であるが、地上に届く紫外線はUV−A及びUV
−BでUV−Cはオゾン層において吸収されて地上には
殆ど達しない。地上にまで達する紫外線の中でUV−B
は皮膚の紅斑や水泡を生じ、またUV−Aは、皮膚の黒
化をもたらし、長期にわたって作用したときには、皮膚
の老化を促進することが認められている。
2. Description of the Related Art Ultraviolet rays are known to cause various changes on the skin. When ultraviolet rays are classified dermatologically, long wavelength ultraviolet rays called 400-320 nm UV-A,
Medium wavelength ultraviolet light called UV-B of 320 to 290 nm,
It is divided into short wavelength ultraviolet rays called UV-C of 290 nm or less. Normally, most of the ultraviolet light to which humans are exposed is sunlight, but the ultraviolet light that reaches the ground is UV-A and UV.
At -B, UV-C is absorbed in the ozone layer and hardly reaches the ground. UV-B in ultraviolet rays reaching the ground
Causes erythema and blisters on the skin, and UV-A has been found to cause darkening of the skin and, when acted on for a long time, promotes aging of the skin.

【0003】従来、UV−B吸収剤は数多く開発されて
きたが、UV−Aは、むしろ夏の海辺で皮膚を健康的な
小麦色にする紫外線として受け入れられていたところか
ら、それほど注目されていなかった。しかし、近年に
は、四季を通じて白い肌であることへの消費者の要望が
高まったことと、皮膚の老化を防ぐことをも併せて、U
V−A吸収剤が注目されるようになってきている。
Heretofore, a number of UV-B absorbers have been developed, but UV-A has received much attention because it has been accepted as an ultraviolet ray that makes the skin healthy brown at the seaside in summer. Did not. However, in recent years, consumer demand for white skin throughout the four seasons and the prevention of skin aging have been increased.
VA absorbers are gaining attention.

【0004】既存のUV−A吸収剤としては、ベンゾフ
ェノン誘導体、ジベンゾイルメタン誘導体、ベンゾトリ
アゾール誘導体などが知られており、化粧料、医薬部外
品等の外用剤に配合され利用されてきた。
[0004] As existing UV-A absorbers, benzophenone derivatives, dibenzoylmethane derivatives, benzotriazole derivatives and the like are known, and have been used by being blended in external preparations such as cosmetics and quasi-drugs.

【0005】一方、近年紫外線吸収剤の配合される化粧
料には、その効果を持続させる必要上、汗や水浴によっ
て容易に流れ落ちしない耐水及び耐油性に優れたジメチ
ルシロキサン等のシリコーン系基剤が広く使用されるよ
うになってきた。これは、シリコーン系基剤の耐水およ
び耐油性機能はもちろん、伸びの良さ、さっぱり感、べ
とつかない等の使用性によるところも大きい。
On the other hand, in recent years, cosmetics to which an ultraviolet absorber is blended include silicone bases such as dimethylsiloxane, which are excellent in water resistance and oil resistance, which do not easily run off due to sweat or a water bath in order to maintain their effect. It is becoming widely used. This is largely due to the water resistance and oil resistance of the silicone base, as well as the good usability such as good elongation, freshness and non-stickiness.

【0006】しかしながら、既存のUV−A吸収剤はシ
リコーン系基剤に対する相溶性が著しく低い。したがっ
て、シリコーン系基剤を配合した外用剤は、従来のUV
−A吸収剤を併せて配合することが困難となり、その使
用量も極く少量に限られ、UV−A吸収剤の持つ機能が
十分に発揮されないという欠点があった。
However, existing UV-A absorbers have extremely low compatibility with silicone bases. Therefore, an external preparation containing a silicone base is a conventional UV
It was difficult to mix the -A absorber together, and the amount used was limited to a very small amount, and there was a disadvantage that the function of the UV-A absorber was not sufficiently exhibited.

【0007】そのため、シリコーン系基剤に溶解し、耐
水性に優れ、UV−A領域の紫外線から皮膚を保護する
UV−A吸収剤の開発が強く望まれるようになった。
For this reason, there has been a strong demand for the development of a UV-A absorber which dissolves in a silicone base, has excellent water resistance, and protects the skin from ultraviolet rays in the UV-A region.

【0008】本発明者は、かかる実情に鑑み鋭意研究を
行った結果、シリコーン系ヒダントイン誘導体が、上述
の性質を満足し得る化合物であることを見いだし、本発
明を完成するに至った。
The present inventor has conducted intensive studies in view of such circumstances, and as a result, has found that a silicone-based hydantoin derivative is a compound that can satisfy the above properties, and has completed the present invention.

【0009】[0009]

【発明が解決しようとする課題】すなわち、本発明の目
的は、シリコーン系基剤に溶解するとともに、UV−A
領域の紫外線を吸収する物質及びそれを配合した皮膚外
用剤を提供することにある。
That is, an object of the present invention is to dissolve in a silicone base,
An object of the present invention is to provide a substance that absorbs ultraviolet rays in a specific region and a skin external preparation containing the substance.

【0010】[0010]

【課題を解決するための手段】この目的は下記の一般式
(1)表されることを特徴とするシリコーン系ヒダン
トイン誘導体、該シリコーン系ヒダントイン誘導体から
なる紫外線吸収剤及び該シリコーン系ヒダントイン誘導
体を含有することを特徴とする皮膚外用剤によって達成
される。
The object of the present invention is to provide a silicone hydantoin derivative represented by the following general formula (1) , an ultraviolet absorbent comprising the silicone hydantoin derivative, and a silicone hydantoin derivative. It is achieved by a skin external preparation characterized by containing.

【0011】[0011]

【化2】 Embedded image

【0012】上記の一般式(1)中、R 1 は炭素数1〜
4のアルキル基、nは2または3、n+m=3、R 2
アルキレン基またはオキシアルキレン基、Xは水酸基、
炭素数1〜8のアルキル基または炭素数1〜8のアルコ
キシ基、aは0〜5の整数を表す
In the above general formula (1), R 1 has 1 to 1 carbon atoms.
An alkyl group of 4, n is 2 or 3, n + m = 3, R 2 is
An alkylene group or an oxyalkylene group, X is a hydroxyl group,
C1-C8 alkyl group or C1-C8 alcohol
The xy group, a represents an integer of 0 to 5 .

【0013】本発明のシリコーン系ヒダントイン誘導体
の式中に定義したR1 の例としては、メチル、エチル、
n−プロピル、イソプロピル、n−ブチル、イソブチ
ル、t−ブチルがあげられる。 2 の例としては、例え
ば、−(CH2 )−、−(CH2 2 −、−(CH2
3 −、−CH2 CH(CH3 )CH2 −、−CH2 CH
2 CH(CH3 )−、−CH(CH3 )CH2 CH2
−、−C(CH32 CH2 CH2 −、−(CH25
−、−CH2 CH2 CH2 CH(CH2 CH3 )−、−
CH2 CH2 CH2 CH2 CH(CH3 )−、−(CH
27 −、−CH2CH2OCH2 CH2 −、−CH2
2 CH2 OCH2 −、等があげられる。Xの例として
は、メトキシ、エトキシ、イソプロポキシ、ブトキシ、
t−ブトキシ、ヘキシロキシ、オクチロキシ等があげら
れる。aはXの置換数を表し0〜5の整数である。
Examples of R 1 defined in the formula of the silicone-based hydantoin derivative of the present invention include methyl, ethyl,
n-propyl, isopropyl, n-butyl, isobuty
And t-butyl . R 2 Examples of, for example, - (CH 2) -, - (CH 2) 2 -, - (CH 2)
3 -, - CH 2 CH ( CH 3) CH 2 -, - CH 2 CH
2 CH (CH 3) -, - CH (CH 3) CH 2 CH 2
-, - C (CH 3) 2 CH 2 CH 2 -, - (CH 2) 5
-, - CH 2 CH 2 CH 2 CH (CH 2 CH 3) -, -
CH 2 CH 2 CH 2 CH 2 CH (CH 3) -, - (CH
2) 7 -, - CH 2 CH 2 OCH 2 CH 2 -, - CH 2 C
H 2 CH 2 OCH 2 -, and the like. Examples of X include methoxy, ethoxy, isopropoxy, butoxy,
t-butoxy, hexyloxy, octyloxy and the like. a represents the number of substitutions of X and is an integer of 0 to 5.

【0014】本発明のシリコーン系ヒダントイン誘導体
は、例えば次の方法により製造することができる。
The silicone-based hydantoin derivative of the present invention can be produced, for example, by the following method.

【0015】[0015]

【化3】 Embedded image

【0016】ベンズアルデヒド誘導体(2)とヒダント
イン(3)をグリシン、アラニン等のアミノ酸またはそ
の塩の存在下、水あるいは水性溶液中で室温〜150℃
で1〜20時間反応させて(4)を得た後、(4)を
N,N−ジメチルホルムアミド、ジメチルスルホキシド
等の溶媒中、KOH、NaOH、K2CO3等の塩基の存
在下、シリコーン化合物A(下記の化4で表される化合
物)(式中、R 1 は炭素数1〜4のアルキル基、R 2 はア
ルキレン基またはオキシアルキレン基、Bはハロゲン元
素でありBr、Cl、I等を表す。また、nは2または
3、n+m=3である。)と室温〜200℃で5分〜5
0時間反応させることにより(1)を得ることができ
る。
The benzaldehyde derivative (2) and the hydantoin (3) are prepared in the presence of an amino acid such as glycine or alanine or a salt thereof in water or an aqueous solution at room temperature to 150 ° C.
In 20 hours was reacted after obtaining (4), (4) a N, N- dimethylformamide, in a solvent such as dimethyl sulfoxide, KOH, NaOH, the presence of a base such as K 2 CO 3, silicone Compound A ( a compound represented by the following chemical formula 4)
Wherein R 1 is an alkyl group having 1 to 4 carbon atoms, and R 2 is
A alkylene group or an oxyalkylene group, and B is a halogen atom
And Br, Cl, I, etc. Also, n is 2 or
3, n + m = 3 . ) And room temperature to 200 ° C for 5 minutes to 5
By reacting for 0 hour, (1) can be obtained.

【0017】[0017]

【化4】 Embedded image

【0018】本発明の皮膚外用剤に用いる基剤は、シリ
コーン系ヒダントイン誘導体が溶解するものであれば何
れでもよいが、特にシリコーン系基剤が、伸びの良さ、
さっぱり感、べとつかない等の使用感や優れた耐水性、
耐油性、さらには汗や水に流れにくいなどの機能が得ら
れるので好ましい。
The base used for the external preparation for skin of the present invention may be any base as long as the silicone-based hydantoin derivative can be dissolved.
Refreshing feeling, non-greasy feeling and excellent water resistance,
Oil resistance is preferred, and furthermore, functions such as hardly flowing into sweat and water are obtained, which is preferable.

【0019】シリコーン系基剤には特に制限はないが、
例えばジメチルポリシロキサン、メチルポリシロキサ
ン、メチルハイドロジェンポリシロキサン等の鎖状ポリ
シロキサン、デカメチルポリシロキサン、ドデカメチル
ポリシロキサン、テトラメチルテトラハイドロジェンポ
リシロキサン等の環状ポリシロキサン、ポリエーテル脂
肪酸変性ポリシロキサン、高級アルコール変性ポリシロ
キサン、アミノ酸変性ポリシロキサン等が用いられる。
The silicone base is not particularly limited,
For example, chain polysiloxanes such as dimethylpolysiloxane, methylpolysiloxane and methylhydrogenpolysiloxane, cyclic polysiloxanes such as decamethylpolysiloxane, dodecamethylpolysiloxane, tetramethyltetrahydrogenpolysiloxane, and polyether fatty acid-modified polysiloxane And higher alcohol-modified polysiloxanes and amino acid-modified polysiloxanes.

【0020】なお、本発明の皮膚外用剤には、通常化粧
品や医薬部外品等の皮膚外用剤に用いられる他の成分、
例えば、油分、潤滑油、本発明以外の紫外線吸収剤、酸
化防止剤、界面活性剤、防腐剤、金属封鎖剤、香料、
水、アルコール、増粘剤等を必要に応じて適宜配合する
ことができる。本発明の皮膚外用剤は、特にその適用分
野を限定するものではなく、本発明に用いるシリコーン
系ヒダントイン誘導体の特性と目的に応じ、化粧料、医
薬部外品等に利用され得るものである。
The external preparation for skin of the present invention includes other components usually used in external preparations for skin such as cosmetics and quasi-drugs,
For example, oil, lubricating oil, ultraviolet absorbers other than the present invention, antioxidants, surfactants, preservatives, sequestering agents, fragrances,
Water, alcohol, a thickener, and the like can be appropriately added as needed. The external preparation for skin of the present invention is not particularly limited in its application field, and can be used in cosmetics, quasi-drugs, and the like according to the characteristics and purpose of the silicone-based hydantoin derivative used in the present invention.

【0021】ここで、本発明の皮膚外用剤の剤型は任意
であり、パウダー状、クリーム状、ペースト状、スチッ
ク状、液状、スプレー状、ファンデーション状等、何れ
の剤型でもかまわず、また乳化剤を用いてW/O型ある
いはO/W型に乳化しても良い。その配合量は上記の剤
型によっても異なるが、一般には、0.1〜30重量%
が好ましく、更に好ましくは0.2〜20重量%であ
る。
Here, the dosage form of the external preparation for skin of the present invention is arbitrary, and any dosage form such as powder, cream, paste, stick, liquid, spray, foundation and the like may be used. It may be emulsified into a W / O type or an O / W type using an emulsifier. The compounding amount varies depending on the above-mentioned dosage form, but is generally 0.1 to 30% by weight.
And more preferably 0.2 to 20% by weight.

【0022】[0022]

【実施例】次に実施例をあげて本発明をさらに説明す
る。なお、本発明は、これらによって限定されるもので
はない。
The present invention will be further described with reference to the following examples. The present invention is not limited by these.

【0023】実施例1 (1)3,4−ジメトキシベンズアルデヒド83.0
g、ヒダントイン50.0g、グリシン28.1g、水
酸化ナトリウム7.5g、水200mlを約75℃で8時
間撹拌した。冷却後、得られた結晶をろ取し、水洗後乾
燥し、5−(3,4−ジメトキシベジリデン)ヒダント
イン(化)112.4g(収率90.6%)を得た。
Example 1 (1) 3,3.0-dimethoxybenzaldehyde 83.0
g, 50.0 g of hydantoin, 28.1 g of glycine, 7.5 g of sodium hydroxide and 200 ml of water were stirred at about 75 ° C. for 8 hours. After cooling, the obtained crystals were collected by filtration, washed with water, and dried to obtain 112.4 g of 5- (3,4-dimethoxybenzylidene) hydantoin (Formula 5 ) (yield: 90.6%).

【0024】[0024]

【化5】 Embedded image

【0025】(2)N,N−ジメチルホルムアミド(D
MF)50mlに上記5−(3,4−ジメトキシベジリデ
ン)ヒダントイン12.40g、下記化で示されるシ
リコーン化合物16.42g、無水炭酸カリウム4.1
5gを加え、約100℃で3時間撹拌した。
(2) N, N-dimethylformamide (D
In 50 ml of MF) 12.40 g of the above 5- (3,4-dimethoxybedylidene) hydantoin, 16.42 g of a silicone compound represented by the following formula 6 , and anhydrous potassium carbonate 4.1.
5 g was added, and the mixture was stirred at about 100 ° C. for 3 hours.

【0026】[0026]

【化6】 Embedded image

【0027】(3)冷却後、不溶物をろ別し、減圧下で
DMFを留去し、微黄色の固体を得た。この固体をメタ
ノールから再結晶し、下記化で示される本発明のシリ
コーン系ヒダントイン誘導体17.93g(収率70.
3%)を得た。
(3) After cooling, insolubles were filtered off and DMF was distilled off under reduced pressure to obtain a pale yellow solid. The solid was recrystallized from methanol, a silicone-based hydantoin derivatives 17.93G (yield 70 of the present invention represented by the following formula 7.
3%).

【0028】[0028]

【化7】 Embedded image

【0029】実施例2 (1)シリコーン化合物化を下記化で示されるシリ
コーン化合物20.48gに変えた他は実施例1に準じ
て反応を行い、
[0029] Example 2 (1) except for changing the silicone compound of 6 to silicone compounds 20.48g represented by the following formula 8 was reacted analogously as described in Example 1,

【0030】[0030]

【化8】 Embedded image

【0031】(2)下記化で示される本発明のシリコ
ーン系ヒダントイン誘導体18.02g(収率61.7
%)を得た。
(2) 18.02 g (yield: 61.7) of the silicone-based hydantoin derivative of the present invention represented by the following formula ( 9 ):
%).

【0032】[0032]

【化9】 Embedded image

【0033】実施例3 (1)シリコーン化合物化を下記化10で示されるシ
リコーン化合物17.19gに変えた他は実施例1に準
じて反応を行い、
[0033] Example 3 (1) except for changing the silicone compound of 6 to silicone compounds 17.19g represented by the following formula 10 was reacted analogously as described in Example 1,

【0034】[0034]

【化10】 Embedded image

【0035】(2)下記化11で示される本発明のシリ
コーン系ヒダントイン誘導体19.13g(収率73.
0%)を得た。
[0035] (2) Silicone-based hydantoin derivatives of the present invention represented by the following formula 11 19.13G (yield 73.
0%).

【0036】[0036]

【化11】 Embedded image

【0037】実施例4 (1)シリコーン化合物化を下記化12で示されるシ
リコーン化合物17.19gに変えた他は実施例1に準
じて反応を行い、
[0037] Example 4 (1) except for changing the silicone compound of 6 to silicone compounds 17.19g represented by Formula 12 was reacted analogously as described in Example 1,

【0038】[0038]

【化12】 Embedded image

【0039】(2)下記化13で示される本発明のシリ
コーン系ヒダントイン誘導体17.95g(収率68.
5%)を得た。
[0039] (2) Silicone-based hydantoin derivatives of the present invention represented by Formula 13 17.95 g (yield: 68.
5%).

【0040】[0040]

【化13】 Embedded image

【0041】実施例5 (1)シリコーン化合物化を下記化14で示されるシ
リコーン化合物17.96gに変えた他は実施例1に準
じて反応を行い、
[0041] Example 5 (1) except for changing the silicone compound of 6 to silicone compounds 17.96g represented by Formula 14 was reacted analogously as described in Example 1,

【0042】[0042]

【化14】 Embedded image

【0043】(2)下記化15で示される本発明のシリ
コーン系ヒダントイン誘導体17.40g(収率64.
7%)を得た。
[0043] (2) Silicone-based hydantoin derivatives of the present invention represented by Formula 15 17.40 g (yield 64.
7%).

【0044】[0044]

【化15】 Embedded image

【0045】実施例6 (1)3,4−ジメトキシベンズアルデヒドを3,4,
5−トリメトキシベンズアルデヒド98.0gに変えた
他は実施例1に準じて反応を行い、5−(3,4,5−
トリメトキシベンジリデン)ヒダントイン(化16)1
28.0g(収率92.1%)を得た。
Example 6 (1) 3,4-dimethoxybenzaldehyde was converted to 3,4
The reaction was carried out in the same manner as in Example 1 except that the amount was changed to 98.0 g of 5-trimethoxybenzaldehyde, and 5- (3,4,5-
Trimethoxy benzylidene) hydantoin (of 16) 1
28.0 g (92.1% yield) were obtained.

【0046】[0046]

【化16】 Embedded image

【0047】(2)5−(3,4−ジメトキシベンジリ
デン)ヒダントインを5−(3,4,5−トリメトキシ
ベンジリデン)ヒダントイン13.90gに変えた他は
実施例1に準じて反応を行い、下記化17で示される本
発明のシリコーン系ヒダントイン誘導体20.60gg
(収率76.3%)を得た。
(2) The reaction was carried out according to Example 1, except that 5- (3,4,5-trimethoxybenzylidene) hydantoin was changed to 13.90 g of 5- (3,4,5-trimethoxybenzylidene) hydantoin. silicone hydantoin derivatives of the present invention represented by Formula 17 20.60Gg
(Yield: 76.3%).

【0048】[0048]

【化17】 Embedded image

【0049】なお、化、化、化11、化13、化
、化17の構造は、 1H−NMRスペクトル、赤外吸
収スペクトル及びMSスペクトルにより確認した。
It should be noted that Chemical Formula 7 , Chemical Formula 9 , Chemical Formula 11 , Chemical Formula 13 , Chemical Formula 1
5. The structure of Chemical formula 17 was confirmed by a 1 H-NMR spectrum, an infrared absorption spectrum and an MS spectrum.

【0050】1H−NMRスペクトルは、JNM FX−
270(日本電子株式会社製)を用いて、CDCl3
溶媒(内部基準CHCl3 ) として測定を行った。代
表例として、図1に化1H−NMRスペクトルを示
す。
The 1 H-NMR spectrum was measured by JNM FX-
The measurement was performed using 270 (manufactured by JEOL Ltd.) with CDCl 3 as the solvent (internal standard CHCl 3). As a representative example, FIG. 1 shows a 1 H-NMR spectrum of Chemical Formula 7 .

【0051】赤外吸収スペクトルは、270−30赤外
分光光度計(日立製作所製)を用いて臭化カリウム錠剤
法で測定を行った。代表例として、図2に化の赤外吸
収スペクトルを示す。
The infrared absorption spectrum was measured by a potassium bromide tablet method using a 270-30 infrared spectrophotometer (manufactured by Hitachi, Ltd.). As a typical example, FIG. 2 shows an infrared absorption spectrum of Chemical formula 7 .

【0052】MSスペクトルは、JMSDX−303
(日本電子株式会社製)を用いてEI法で測定した。何
れの化合物においても、分子イオンピーク(M+ )が確
認された。
The MS spectrum was obtained from JMSDX-303.
(Manufactured by JEOL Ltd.) using the EI method. In each case, a molecular ion peak (M + ) was confirmed.

【0053】実施例1〜6で得た化合物について、UV
−2200型分光光度計(島津製作所製)を用いてエタ
ノール溶媒で紫外線吸収スペクトルを測定したところ、
何れもUV−A領域に極大吸収を示した。このことよ
り、本発明のシリコーン系ヒダントイン誘導体は、優れ
たUV−A吸収剤であるといえる。代表例として、図3
に化の紫外線吸収スペクトルを示す。
For the compounds obtained in Examples 1 to 6, UV
When an ultraviolet absorption spectrum was measured with an ethanol solvent using a -200 type spectrophotometer (manufactured by Shimadzu Corporation),
All showed maximum absorption in the UV-A region. From this, it can be said that the silicone-based hydantoin derivative of the present invention is an excellent UV-A absorber. As a representative example, FIG.
2 shows an ultraviolet absorption spectrum of Chemical Formula 7 .

【0054】本発明のシリコーン系ヒダントイン誘導体
のシリコーン系基剤に対する溶解性は、25℃の条件
下、ジメチルポリシロキサン、メチルフェニルポリシロ
キサンへの溶解性を試験した。いずれも、10重量%以
上溶解し、優れた溶解性を示した。
The solubility of the silicone-based hydantoin derivative of the present invention in a silicone-based material was tested at 25 ° C. in dimethylpolysiloxane and methylphenylpolysiloxane. In each case, 10% by weight or more was dissolved, showing excellent solubility.

【0055】また、耐水性・耐油性は、水、50%エタ
ール、流動パラフィン等の油に本発明のシリコーン系ヒ
ダントイン誘導体を撹拌混合し、50℃にて60日間放
置した。その結果、加水分解等は起こらず、耐水性、耐
油性が優れていることを確認した。
The water resistance and oil resistance were as follows. The silicone hydantoin derivative of the present invention was mixed with oil such as water, 50% ethanol, liquid paraffin, and the like, and allowed to stand at 50 ° C. for 60 days. As a result, it was confirmed that hydrolysis and the like did not occur and that water resistance and oil resistance were excellent.

【0056】実施例7 日焼け止め化粧料(油状タイ
プ) (1)デカメチルシクロペンタシロキサン 48.0重量部 (2)ジメチルポリシロキサン(10cs/25℃) 20.0 (3)メチルフェニルポリシロキサン(20cs/25℃) 20.0 (4)シリコーン樹脂 10.0 (5)シリコーン系ヒダントイン誘導体(実施例1の化合物) 2.0
Example 7 Sunscreen cosmetics (oil type) (1) 48.0 parts by weight of decamethylcyclopentasiloxane (2) Dimethylpolysiloxane (10 cs / 25 ° C.) 20.0 (3) Methylphenylpolysiloxane ( (20 cs / 25 ° C.) 20.0 (4) Silicone resin 10.0 (5) Silicone hydantoin derivative (compound of Example 1) 2.0

【0057】(製法)(1)〜(5)を混合し、十分に
溶解した後、ろ過して製品とした。
(Preparation method) (1) to (5) were mixed and dissolved sufficiently, followed by filtration to obtain a product.

【0058】比較例1 実施例7の処方中、(5)を除く以外は実施例7と同様
にして製品を得た。
Comparative Example 1 A product was obtained in the same manner as in Example 7 except that (5) was omitted from the formulation of Example 7.

【0059】実施例8 日焼け止め化粧料(クリーム) (1)デカメチルペンタシロキサン 9.0重量部 (2)流動パラフィン 3.0 (3)イソプロピルミリステート 2.0 (4)ワセリン 5.0 (5)セタノール 5.0 (6)ステアリン酸 3.0 (7)グリセリルモノイソステアレート 3.0 (8)シリコーン系ヒダントイン誘導体(実施例2の化合物) 2.0 (9)防腐剤 0.2 (10)香料 0.2 (11)グリセリン 10.0 (12)プロピレングリコール 5.0 (13)水酸化カリウム 0.2 (14)精製水 52.4Example 8 Sunscreen cosmetics (cream) (1) 9.0 parts by weight of decamethylpentasiloxane (2) Liquid paraffin 3.0 (3) Isopropyl myristate 2.0 (4) Vaseline 5.0 ( 5) Cetanol 5.0 (6) Stearic acid 3.0 (7) Glyceryl monoisostearate 3.0 (8) Silicone hydantoin derivative (compound of Example 2) 2.0 (9) Preservative 0.2 (10) Fragrance 0.2 (11) Glycerin 10.0 (12) Propylene glycol 5.0 (13) Potassium hydroxide 0.2 (14) Purified water 52.4

【0060】(製法)(1)〜(10)を70℃で加熱
撹拌して油相部とした。(11)〜(14)を70℃に
加熱し完全溶解した後、水相部とした。油相部を水相部
に添加し、乳化機にて乳化した。乳化物を30℃まで冷
却し製品とした。
(Production method) (1) to (10) were heated and stirred at 70 ° C. to obtain an oil phase. After heating (11) to (14) to 70 ° C. and completely dissolving them, they were made into an aqueous phase. The oil phase was added to the aqueous phase and emulsified by an emulsifier. The emulsion was cooled to 30 ° C. to obtain a product.

【0061】比較例2 実施例8の処方中(8)を除く以外は実施例8と同様に
して製品を得た。
Comparative Example 2 A product was obtained in the same manner as in Example 8 except that (8) was omitted from the formulation of Example 8.

【0062】実施例9 日焼け止めローション (1)ジメチルポリシロキサン(5cs/25℃) 10.0重量部 (2)メチルフェニルポリシロキサン(20cs/25℃) 7.0 (3)ステアリン酸 1.0 (4)シリコーン系ヒダントイン誘導体(実施例3の化合物)10.0 (5)防腐剤 0.2 (6)香料 0.2 (7)グリセリン 5.0 (8)水酸化カリウム 0.2 (9)精製水 66.4Example 9 Sunscreen lotion (1) 10.0 parts by weight of dimethylpolysiloxane (5 cs / 25 ° C.) (2) methylphenylpolysiloxane (20 cs / 25 ° C.) 7.0 (3) Stearic acid 1.0 (4) Silicone hydantoin derivative (compound of Example 3) 10.0 (5) Preservative 0.2 (6) Fragrance 0.2 (7) Glycerin 5.0 (8) Potassium hydroxide 0.2 (9) ) Purified water 66.4

【0063】(製法)(1)〜(6)を70℃で加熱撹
拌して油相部とした。(7)〜(9)を70℃に加熱し
完全溶解した後、水相部とした。油相部を水相部に添加
し、乳化機にて乳化した。乳化物を30℃まで冷却し製
品とした。
(Production method) (1) to (6) were heated and stirred at 70 ° C. to obtain an oil phase. After heating (7) to (9) to 70 ° C. and completely dissolving the mixture, the mixture was treated as an aqueous phase. The oil phase was added to the aqueous phase and emulsified by an emulsifier. The emulsion was cooled to 30 ° C. to obtain a product.

【0064】比較例3 実施例9の処方中(4)を除く以外は実施例9と同様に
して製品を得た。
Comparative Example 3 A product was obtained in the same manner as in Example 9 except that (4) was omitted from the formulation of Example 9.

【0065】以上の如くして得られた実施例7〜9およ
び比較例1〜3について紫外線防止効果の測定を行っ
た。測定方法は、人の背部に本発明品を配合した上記化
粧料を2mg/cm2の量で塗布し、15分後UV−A照射を
行った。UV−A照射は、BLBランプで、365nm、
9J/cm2 のエネルギー量の紫外線を照射し、下記の式
を用いて最小黒化量(MMD)を求めた。
With respect to Examples 7 to 9 and Comparative Examples 1 to 3 obtained as described above, the effect of preventing ultraviolet rays was measured. The measuring method was as follows. The above-mentioned cosmetic containing the product of the present invention was applied to the back of a person in an amount of 2 mg / cm 2 , and 15 minutes later, UV-A irradiation was performed. UV-A irradiation is performed using a BLB lamp at 365 nm,
Ultraviolet rays having an energy amount of 9 J / cm 2 were irradiated, and the minimum blackening amount (MMD) was determined using the following equation.

【0066】[0066]

【数1】 (Equation 1)

【0067】この結果を表1に示した。Table 1 shows the results.

【0068】[0068]

【表1】 [Table 1]

【0069】表1からわかるように実施例のMMD値
は、いずれも比較例より高くなっている。すなわち、本
発明のシリコーン系ヒダントイン誘導体を配合すること
により優れた紫外線防止効果が得られることがわかる。
As can be seen from Table 1, the MMD values of the examples are higher than those of the comparative examples. That is, it is understood that an excellent ultraviolet ray preventing effect can be obtained by blending the silicone hydantoin derivative of the present invention.

【0070】[0070]

【発明の効果】本発明のシリコーン系ヒダントイン誘導
体は、UV−A領域に極大吸収を有する優れた紫外線吸
収剤である。また、本発明の紫外線吸収剤は、耐水性、
耐油性に優れているので、基剤や他の配合成分を自由に
選べる皮膚外用剤を提供することができると同時に、日
焼け止め化粧料として炎天下の過酷な条件下に曝露した
場合においても優れた効果を示すことは明らかである。
The silicone hydantoin derivative of the present invention is an excellent ultraviolet absorber having a maximum absorption in the UV-A region. Further, the ultraviolet absorber of the present invention has water resistance,
Because it has excellent oil resistance, it can provide an external preparation for the skin in which the base and other components can be freely selected, and at the same time, is excellent even when exposed to severe conditions under the scorching sun as a sunscreen cosmetic. It is clear that it shows an effect.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化1H−NMRスペクトルを示す図
である。
FIG. 1 is a diagram showing a 1 H-NMR spectrum of a silicone-based hydantoin derivative 7 obtained in Example 1 of the present invention.

【図2】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化の赤外吸収スペクトルを示す図であ
る。
FIG. 2 is a view showing an infrared absorption spectrum of a silicone-based hydantoin derivative 7 obtained in Example 1 of the present invention.

【図3】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化の紫外線吸収スペクトルを示す図で
ある。
FIG. 3 is a view showing an ultraviolet absorption spectrum of a silicone-based hydantoin derivative 7 obtained in Example 1 of the present invention.

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 一般式(1) 【化1】 但し、式中、R 1 は炭素数1〜4のアルキル基、nは
2または3、n+m=3、R 2 はアルキレン基またはオ
キシアルキレン基、Xは水酸基、炭素数1〜8のアルキ
ル基または炭素数1〜8のアルコキシ基、aは0〜5の
整数を表す。)で表されることを特徴とするシリコーン
系ヒダントイン誘導体。
1. A compound of the general formula (1) ( Wherein, R 1 is an alkyl group having 1 to 4 carbon atoms, and n is
2 or 3, n + m = 3, R 2 is an alkylene group or an oxyalkylene group, X is a hydroxyl group, an alkyl group or an alkoxy group having 1 to 8 carbon atoms having 1 to 8 carbon atoms, a is an integer of 0 to 5 . A silicone-based hydantoin derivative represented by the formula:
【請求項2】 請求項1記載のシリコーン系ヒダントイ
ン誘導体からなる紫外線吸収剤。
2. An ultraviolet absorbent comprising the silicone-based hydantoin derivative according to claim 1.
【請求項3】 請求項1記載のシリコーン系ヒダントイ
ン誘導体を含有することを特徴とする皮膚外用剤。
3. An external preparation for skin comprising the silicone-based hydantoin derivative according to claim 1.
JP26583893A 1993-09-28 1993-09-28 Silicone hydantoin derivatives, UV absorbers and skin external preparations Expired - Fee Related JP3145237B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26583893A JP3145237B2 (en) 1993-09-28 1993-09-28 Silicone hydantoin derivatives, UV absorbers and skin external preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26583893A JP3145237B2 (en) 1993-09-28 1993-09-28 Silicone hydantoin derivatives, UV absorbers and skin external preparations

Publications (2)

Publication Number Publication Date
JPH0797383A JPH0797383A (en) 1995-04-11
JP3145237B2 true JP3145237B2 (en) 2001-03-12

Family

ID=17422770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26583893A Expired - Fee Related JP3145237B2 (en) 1993-09-28 1993-09-28 Silicone hydantoin derivatives, UV absorbers and skin external preparations

Country Status (1)

Country Link
JP (1) JP3145237B2 (en)

Also Published As

Publication number Publication date
JPH0797383A (en) 1995-04-11

Similar Documents

Publication Publication Date Title
JPH05230041A (en) S-triazine derivative containing benzylidenecamphor substituent, its production and cosmetic composition
KR910009820B1 (en) Silicone type cinnamic acid derivative,preparation method thereof uv-ray absorber,and external skin treatment agent
JP2984300B2 (en) Cosmetic composition
US5061479A (en) Use of diorganopolysiloxanes containing a 3-benzylidene camphor functional group in cosmetics and new cosmetic compositions containing these compounds, intended for protecting the skin and hair
KR20060052830A (en) Dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds
JP3088224B2 (en) Silicone hydantoin derivatives, UV absorbers and skin external preparations
JP3145237B2 (en) Silicone hydantoin derivatives, UV absorbers and skin external preparations
US5315022A (en) Silicone type cinnamic acid derivative, preparation method thereof, UV-ray absorber, and external skin treatment agent
JP3178951B2 (en) Silicone hydantoin derivatives, UV absorbers and skin external preparations
JP3497246B2 (en) Benzylidene hydantoin derivative, ultraviolet absorber and external preparation for skin containing the same
JP3170386B2 (en) Silicone hydantoin derivatives, UV absorbers and skin external preparations
JP3162878B2 (en) Silicone cinnamic acid derivatives, UV absorbers and skin external preparations
JP3088222B2 (en) UV absorber and external preparation for skin
JP3170389B2 (en) Silicone hydantoin derivatives, UV absorbers and skin external preparations
JP3088223B2 (en) UV absorber and external preparation for skin
US5225583A (en) Alkyl-aryl 1,3-propanedione silicone derivative and an external preparation for skin with the derivative compounded therein
WO2008041525A1 (en) Furylmethylene malonamide compound and salt thereof, ultraviolet ray absorbent, and external preparation for skin
JP3447804B2 (en) Benzal malonate derivative having organosilicon group, method for producing the same, ultraviolet absorber and cosmetic containing the same
JPH08245356A (en) Method for utilizing dihydroxyacetone
JPH05186430A (en) Benzylidenehydantoin derivative and skin external preparation blended with the same
JPH0717983A (en) 5-allylpentadienoic acid silicon derivative, ultraviloet rays absorbent and skin external agent compounded with the same
JP3976816B2 (en) Hydantoin derivatives, UV absorbers and skin external preparations
JPH049355A (en) Cinnamic acid derivative, uv absorber and dermatic external drug containing the same
JPH0717892A (en) 1,3-butadienyl ketone derivative, ultraviolet ray absorber and skin external preparation containing the same blended therein
JPH05186429A (en) Benzylidenehydantoin derivative and skin external preparation blended with the same

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees